Bandar A. Alyami

ORCID: 0000-0002-6374-917X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Natural Antidiabetic Agents Studies
  • Computational Drug Discovery Methods
  • Electrochemical sensors and biosensors
  • Advanced Nanomaterials in Catalysis
  • Advanced biosensing and bioanalysis techniques
  • Medicinal Plants and Bioactive Compounds
  • Synthesis and biological activity
  • Medicinal Plants and Neuroprotection
  • Nanoparticles: synthesis and applications
  • Phytochemistry and Biological Activities
  • Phytochemicals and Antioxidant Activities
  • Cholinesterase and Neurodegenerative Diseases
  • Cardiac pacing and defibrillation studies
  • Electrochemical Analysis and Applications
  • Cardiac Structural Anomalies and Repair
  • Atrial Fibrillation Management and Outcomes
  • Metabolomics and Mass Spectrometry Studies
  • Nanocluster Synthesis and Applications
  • Cardiac Valve Diseases and Treatments
  • Adsorption and biosorption for pollutant removal
  • Heart Failure Treatment and Management
  • Cardiac Imaging and Diagnostics
  • Pericarditis and Cardiac Tamponade
  • Cardiac Arrhythmias and Treatments
  • Synthesis and Biological Evaluation

Najran University
2020-2024

West Virginia University
2021-2024

Wayne State University
2024

Morgantown High School
2023

Bahria University
2023

Detroit Medical Center
2023

Augusta University Health
2023

Saint Vincent Hospital
2023

University of Georgia
2023

Regional Medical Center
2023

To obtain a multipotent framework that can target simultaneously COX-2, 5-LOX, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) to treat neuroinflammation, series of derivatives containing pyrimidine pyrrolidine cores were rationally synthesized evaluated. Pyrazoline–pyrimidine hybrid (23g), (3-acetylcoumarin derivative pyrrolidin-1-yl)benzenesulfonamide (27), tacrine (pyrrolidin-1-yl)benzenesulfonamide (31, 38) displayed excellent in vitro COX-2 inhibition having IC50 value the...

10.1021/acschemneuro.1c00507 article EN ACS Chemical Neuroscience 2021-10-13

Prostrate knotweed also called Polygonum aviculare is an important edible plant. The polygonum majorly known for the phenolics and antioxidants. antioxidants combat excessive free radicals within body. are implicated in various other diseases like diabetes, Alzheimer’s, inflammation. This study was aimed at exploring antioxidant bioactives their derivatizations to produce new molecules with advanced pharmacological features. We have isolated six compounds (1–6) from aviculare. Furthermore,...

10.1155/2022/3127480 article EN cc-by Oxidative Medicine and Cellular Longevity 2022-02-27

Abstract Background According to the recent global cancer statistics, breast is leading cause of deaths among women with 2.3 million new cases globally. Likewise, cervical also causes mortality women. Polygonum hydropiper traditionally known for its cytotoxic effects and several bioactive compounds were isolated from it. This study was aimed isolate potential anticancer most potent fractions evaluate their potentials. Methods Based on our earlier studies, active including chloroform ethyl...

10.1186/s12906-021-03411-1 article EN cc-by BMC Complementary Medicine and Therapies 2021-09-24

Medicinal plants and essentials oils are well known for diverse biological activities including antidiabetic potential. This study was designed to isolate essential from the leaves of Persicaria hydropiper L. (P. hydropiper), perform its phytochemical analysis, explore in vitro effects.P. (Ph.Los) were extracted using a hydrodistillation apparatus subjected analysis gas chromatography mass spectrometry (GC-MS) technique. Ph.Lo tested against two vital enzymes α-glucosidase α-amylase which...

10.1155/2022/7924171 article EN Evidence-based Complementary and Alternative Medicine 2022-01-19

Natural phenolic compounds and Phenolics-rich medicinal plants are also of great interest in the management diabetes. The current study was aimed to analyze phenolics P. hydropiepr L extracts via HPLC-DAD analysis assess their anti-diabetic potentials using in-vitro in-silico approaches.Plant crude methanolic extract (Ph.Cme) evaluated for presence analysis. Subsequently, samples including (Ph.Cr), hexane (Ph.Hex), chloroform (Ph.Chf), ethyl acetate (Ph.EtAc), butanol (Ph.Bt), aqueous...

10.1186/s12906-022-03510-7 article EN cc-by BMC Complementary Medicine and Therapies 2022-01-27

Diabetes mellitus is a common disease effecting the lifestyles of majority world population. In this research work, we have embarked potential role crude extracts and isolated compounds Notholirion thomsonianum for management diabetes mellitus.The N. were initially evaluated α-glucosidase, α-amylase antioxidant activities. The from activity based potent solvent fraction. structures confirmed with NMR MS analyses. tested α-amylase, protein tyrosine phosphatase 1B (PTP1B) DPPH molecular...

10.1186/s12906-021-03443-7 article EN cc-by BMC Complementary Medicine and Therapies 2021-10-27

Organocatalytic asymmetric Michael addition is a strong approach for C-C bond formation. The objective of the study to design molecules by exploiting efficiency Adducts. We proceeded with synthesis adducts tailoring substitution pattern on maleimide and trans-β-nitro styrene as acceptors. synthesized compounds were evaluated dual cyclooxygenases (COX) lipoxygenase (LOX) inhibition.The (4, 9-11) through additions. (COX-1 2) (5-LOX) assays used in vitro evaluations compounds. After acute...

10.2147/dddt.s292826 article EN cc-by-nc Drug Design Development and Therapy 2021-03-01

The study was planned to investigate the phytochemicals, antidiabetic and antioxidant studies of A. consanguineum.The preliminary were performed on crude extract different solvent fractions. Based potency, chloroform fraction semi-purified phyto-fractions CHF-1 - 5. Furthermore, CHF-3 subjected isolation pure compounds using column chromatography. α-glucosidase, α-amylase assays (DPPH, ABTS, H2O2) all samples. in-vivo experiments 1 2 also oral glucose tolerance test. Docking α-glucosidase...

10.1186/s12906-022-03639-5 article EN cc-by BMC Complementary Medicine and Therapies 2022-06-13
Coming Soon ...